Ranked #1
Palliative care in oncology
Palliative care in oncology
Stein Kaasa and Jon Loge discuss their new Commission on palliative care.
19 Oct 2018
•
10mins
Ranked #2
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
26 Jul 2017
•
8mins
Similar Podcasts
Journal of Clinical Oncology (JCO) Podcast
ASCO Daily News
JCO Oncology Practice Podcast
Hematologic Oncology Update
Listen to The Lancet Haematology
ASCO Guidelines
JAMA Oncology Author Interviews
Listen to The Lancet
Listen to The Lancet Infectious Diseases
Listen to The Lancet Respiratory Medicine
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
The Lancet News
Listen to The Lancet Gastroenterology & Hepatology
Listen to The Lancet Diabetes & Endocrinology
Listen to The Lancet Neurology
Ranked #3
Global review of cancer control
Global review of cancer control
Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
27 Sep 2018
•
10mins
Ranked #4
Are patient reported outcomes consistent?
Are patient reported outcomes consistent?
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, rep... Read more
31 Aug 2018
•
8mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Changing incidence of adolescent cancer
Changing incidence of adolescent cancer
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information Syste... Read more
31 Aug 2018
•
8mins
Ranked #6
Diffuse intrinsic pontine glioma
Diffuse intrinsic pontine glioma
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery... Read more
14 Aug 2018
•
22mins
Ranked #7
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesoph... Read more
30 Jun 2018
•
9mins
Ranked #8
Gender and cancer immunotherapy efficacy
Gender and cancer immunotherapy efficacy
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy o... Read more
1 Jun 2018
•
9mins
Ranked #9
PROs in regulatory decision making
PROs in regulatory decision making
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision... Read more
25 Apr 2018
•
11mins
Ranked #10
Vulvar field resection
Vulvar field resection
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma base... Read more
29 Mar 2018
•
13mins
Ranked #11
Chromatin organisation and cancer prognosis
Chromatin organisation and cancer prognosis
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse ch... Read more
1 Mar 2018
•
7mins
Ranked #12
Trial design for brain metastases: The Lancet Oncology: Jan 2018
Trial design for brain metastases: The Lancet Oncology: Jan 2018
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
30 Dec 2017
•
11mins
Ranked #13
Lung cancer screening: The Lancet Oncology: November 27, 2017
Lung cancer screening: The Lancet Oncology: November 27, 2017
John Field discusses a European position statement on lung cancer screening using low-dose CT.
28 Nov 2017
•
10mins
Ranked #14
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment a... Read more
1 Nov 2017
•
10mins
Ranked #15
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver met... Read more
2 Sep 2017
•
4mins
Ranked #16
Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell ... Read more
29 Jun 2017
•
7mins
Ranked #17
EANO and palliative care: The Lancet Oncology: June 2, 2017
EANO and palliative care: The Lancet Oncology: June 2, 2017
Martin Taphoorn outlines the importance of palliative care for patients with gliomas.
3 Jun 2017
•
8mins
Ranked #18
Head and neck cancer Series: The Lancet Oncology: April 26, 2017
Head and neck cancer Series: The Lancet Oncology: April 26, 2017
Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.
26 Apr 2017
•
17mins
Ranked #19
18F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017
18F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017
Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patien... Read more
30 Mar 2017
•
5mins
Ranked #20
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
2 Mar 2017
•
18mins
